Analyst Ratings For Allscripts Healthcare Solutions (NASDAQ:MDRX)
Today, Cantor Fitzgerald initiated coverage on Allscripts Healthcare Solutions (NASDAQ:MDRX) with a Neutral.
There are 1 sell rating, 10 hold ratings, 8 buy ratings on the stock.
The current consensus rating on Allscripts Healthcare Solutions (NASDAQ:MDRX) is Hold (Score: 2.37) with a consensus target price of $15.04 per share, a potential 42.79% upside.
Some recent analyst ratings include
1/5/2017-Cantor Fitzgerald initiated coverage with a Neutral rating.
1/3/2017-Canaccord Genuity Reiterated Rating of Buy.
12/13/2016-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight ” rating to a ” Underweight” rating. They now have a $10.00 price target on the stock, up previously from $15.00 .
12/2/2016-Dougherty & Co initiated coverage with a Neutral rating.
11/10/2016-Deutsche Bank AG was Downgraded by analysts at Deutsche Bank AG from a “Buy ” rating to a ” Hold” rating. They now have a $11.00 price target on the stock, up previously from $14.00 .
10/30/2016-J P Morgan Chase & Co initiated coverage with a Buy rating.
10/23/2016-Argus Reiterated Rating of Buy.
Dividend information for Allscripts Healthcare Solutions (NASDAQ:MDRX)
.
On 9/15/2016 James Hewitt, SVP, sold 17,500 with an average share price of $13.00 per share and the total transaction amounting to $227,500.00.
On 9/15/2016 Paul Black, CEO, sold 15,000 with an average share price of $13.00 per share and the total transaction amounting to $195,000.00.
On 7/11/2016 Dennis Olis, SVP, sold 7,000 with an average share price of $14.00 per share and the total transaction amounting to $98,000.00.
On 7/1/2016 James Hewitt, SVP, sold 17,500 with an average share price of $13.00 per share and the total transaction amounting to $227,500.00.
On 6/13/2016 Paul Black, CEO, sold 15,000 with an average share price of $13.04 per share and the total transaction amounting to $195,600.00.
On 6/13/2016 Richard J Poulton, President, sold 10,000 with an average share price of $13.03 per share and the total transaction amounting to $130,300.00.
About Allscripts Healthcare Solutions (NASDAQ:MDRX)
Allscripts Healthcare Solutions, Inc. delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. Its Population Health segment includes sale of health management and coordinated care solutions that are focused on hospitals, health systems, other care facilities and accountable care organizations. These solutions enable clients to connect, transition, analyze, and coordinate care across the care community.
Recent Trading Activity for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Shares of Allscripts Healthcare Solutions closed the previous trading session at 10.53 down -0.26 -2.41% with 4,639,744 shares trading hands.
The post Analyst Activity – Cantor Fitzgerald Initiates Coverage On Allscripts Healthcare Solutions (NASDAQ:MDRX) With a Neutral appeared first on Market Exclusive.